Health.amREFERENCES
1. Barquest N, Domingo P. Smallpox: the triumph over the most terrible of the ministers of death. Ann Internal Med. 1997;127:627.
2. US Centers for Disease Control and Prevention. Ten great public health achievements in the twentieth century, 1900-1999. http://www.cdc.gov/od/co/media/tengpha.htm.
3. Parker AA. Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States. New Engl J Med. 2006;355:1184.
4. Okonek BAM, Peters PM. Vaccines: how and why. http://www.accessexcellence.org.
5. Baxby D. Vaccination: Jenner's Legacy. Berkeley, UK: Jenner Educational Trust; 1994. 6. Parish HJ. A History of Immunization. Edinburgh, UK: Livingstone; 1965.
7. Gross CP, Sepkowitz K. The myth of the medical breakthrough: smallpox, vaccination, and Jenner reconsidered. Int J Infect Dis. 1998;3:54-60.
8. Salmon DA, et al. Compulsory vaccination and conscientious or philosophical exemptions: past, present, and future. Lancet. 2006;367(9508):436-442.
9. World Health Organization. Smallpox. http://www.who.int.
10. Hansen B. America's first medical breakthrough: how popular excitement about a French rabies cure in 1885 raised new expectations for medical progress. Am Hist Rev. 1998;103: 373-418.
11. Payette PJ, Davis HL. History of vaccines and positioning of current trends. Curr Drug Targets Infect Disord. 2001;1:241-247.
12. Cody CL, et al. Nature and rates of adverse reactions associated with DPT and DT immunizations in infants and children. Pediatrics. 1981;68:650-660.
13. Hennessen W, Quest U. Adverse reactions after pertussis vaccination. International Symposium on Immunization: benefits vs. risk factors. Brussels Dev Biol Stan. 1979;43:95-100.
14. Hinman AAR, Koplan J. Pertussis and pertussis vaccine: reanalysis of benefits, risks, and costs. JAMA. 1984;251:3109-3113.
15. Institute of Medicine. DPT Vaccine and Chronic Nervous System Dysfunction: A New Analysis. Washington, DC: National Academy of Sciences; 1999.
16. Alderslade R, et al. The National Childhood Encephalopathy Study: a report on 1000 cases of serious neurological disorders in infants and young children from the NCES research team. In: Department of Health and Social Security, ed. Whooping Cough: Reports from the Committee on the Safety of Medicines and the Joint Committee on Vaccination and Immunisation. London: Her Majesty's Stationery Office: 1981.
17. Blume S, Geesink I. Essay on science and society: a brief history of polio vaccines. Science. 2000;288(5471):1593-1594.
18. Biddle W. A Field Guide to Germs. New York: Henry Holt; 1995.
19. World Health Organization. Pneumococcal conjugate vaccine for childhood immunization: WHO position paper. Wkly Epidemiol Rec. 2007;82:93-104.
20. Kung HC, et al. Deaths: final data for 2005. Natl Vital Stat Rep. 2008;56:1-120.
21. Grijalva CG, et al. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics. 2006;118:865-873.
22. Grijalva CG, Griffin MR. Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USA. Expert Rev Vaccines. 2008;7:83-95.
23. World Health Organization. Pneumococcal conjugate vaccine for childhood immunization: WHO position paper. Wkly Epidemiol Rec. 2007;82:93-104.
24. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2000;49:1-35.
25. Whitney CG, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737-1746.
26. Hennessy TW, et al. Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity. Vaccine. 2005;23:5464-5473.
27. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease: United States, 1998-2003. MMWR. 2005;54:893-897.
28. Lexau CA. The changing epidemiology of pneumococcal pulmonary disease in the era of the heptavalent vaccine. Curr Infect Dis Rep. 2008;10:229-235.
29. Lexau CA, et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA. 2005;294:2043-2051.
30. Haber M, et al. Herd immunity and pneumococcal conjugate vaccine: a quantitative model. Vaccine. 2007;25:5390-5398.
31. Fireman B, Black SB, Shinefield HR, Lee J, Lewis E, Ray P. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J. 2003;22:10-6.
32. Palmu AA, et al. The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children. Pediatr Infect Dis J. 2004;23:732-738.
33. Poehling KA, et al. Population-based impact of pneumococcal conjugate vaccine in young children. Pediatrics. 2004;114:755-761.
34. Poehling KA, et al. Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Pediatrics. 2007;119:707-715.
35. Progress in introduction of pneumococcal conjugate vaccine: worldwide, 2000-2008. MMWR 2008;57:1148-1151.
36. Bliss, SJ et al. The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease. Lancet Infect Dis. 2008;8:67-80.
37. Global progress toward universal childhood hepatitis B vaccination, 2003. MMWR 2003;52:868-870.
38. Progress toward introduction of Haemophilus influenzae type b vaccine in lowincome countries: worldwide, 2004-2007. MMWR. 2008;57:148-151.
39. Immunization Strategic Advisory Group of Experts. Meeting of the Immunization Strategic Advisory Group of Experts, April 2008: conclusions and recommendations. Wkly Epidemiol Rec. 2008;83(22):193-208.
40. Hicks LA, et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis. 2007;196:1346-1354.
41. Pichichero ME, Casey JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA. 2007;298:1772-1778.
42. Javitt G, et al. Assessing mandatory HPV vaccination: who should call the shots? J Law Med Ethics. 2008;36(2):214, 384-395.
43. Rockoff JD. Mandatory Gardasil vaccination would be unwise, academics say. Wall Street Journal. November 11, 2008.
44. Centers for Disease Control and Prevention. Reports of health concerns following HPV vaccination. http://www.cdc.gov/vaccinesafety/vaers/gardasil.htm. Published 2008.
45. Centers for Disease Control and Prevention. Information from FDA and CDC on Gardasil and its safety. http://www.cdc.gov/vaccinesafety/vaers/FDA_and_CDC_Statement. htm. Published 2008.
46. National Conference of State Legislatures. HPV vaccines. http://www.ncsl.org/programs/ health/HPVvaccine.htm. Published 2008.
47. Blumenthal R. Texas is first to require cancer shots for schoolgirls. New York Times. February 3, 2007.
48. Rosenthal E. Drug makers' push leads to cancer vaccines' rise. New York Times. August 19, 2008.
49. Saul S, Pollack A. Furor on rush to require cervical cancer vaccine. New York Times. February 17, 2007.
50. Pollack A, Saul S. Merck to halt lobbying for vaccine for girls. New York Times. February 21, 2007.
51. Measles and school immunization requirements: United States. MMWR. 1978;27: 303-304.
52. Omer SB, et al. Nonmedical exemptions to school immunization requirements. Secular trends and association of state policies with pertussis incidence. JAMA. 2006;296:1757-1763.
53. Salmon DA, et al. Exemptions to school immunization requirements: the role of school-level requirements, policies, and procedures. Am J Public Health. 2005; 95:436-440.
54. Chen R, et al. Investigation of a possible association between influenza vaccination and Guillain-Barre syndrome in the United States, 1990-1991. Post-Mark Surveill. 1992;6:5.
55. Kaker JP. The pertussis vaccine controversy in Great Britain, 1974-1986. Vaccine. 2003;21:4003-4010.
56. Meszaros JR, et al. Cognitive processes and the decisions of some parents to forgo pertussis vaccination for their children. J Clin Epidemiol. 1996;49:697-703.
57. Petousis-Harris H, et al. Family physician perspectives on barriers to childhood immunization. Vaccine. 2004;22:2340-2344.
58. Gellin BG, Mailbach EW, Marcuse EK. Do parents understand immunizations? a national telephone survey. Pediatrics. 2000;10(5):1097-1102.
59. Offit PA, et al. Addressing parents' concerns: do multiple vaccines overwhelm or weaken the infant's immune system? Pediatrics. 2002;109:124-129.
60. Abbott VP. Web page quality: can we measure it and what do we find? a report of exploratory findings. J Public Health Med. 2000;22:191-197.
61. Zimmerman RK, et al. Vaccine criticism on the World Wide Web. J Med Internet Research. 2005;7:2.
62. Wakefield AJ, et al. Ileal-lymphoid-nodular hyperplasia, nonspecific colitis, and pervasive developmental disorder in children. Lancet. 1998;351(9(30):637-641.
63. Subcommittee on Human Rights and Wellness, Committee about Reform, US House of Representatives. The Congressional Record. May 21, 2003.
64. Offit PA. Inoculated against facts. New York Times. March 31, 2008.
65. Harris G. Deal in an autism case fuels debate on vaccine. New York Times. March 8, 2008.
66. Parker-Pope T. Will a 9-year-old change the vaccine debate? New York Times. April 12, 2008.
67. Harris G. Court hears more claims of vaccine-autism link. New York Times. May 13, 2008.
68. Court allows family to sue vaccine maker. Augusta Chronicle. October 7, 2008.
69. Folb PI, et al. A global perspective on vaccine safety and public health: the Global Advisory Committee on Vaccine Safety. Am J Public Health. 2004;94: 1926- 1931.
70. McNeil DG. Malaria vaccine proves effective. New York Times. October 15, 2004.
71. Grady D. Before shortage of flu vaccine, many warnings. New York Times. October 17, 2004.
72. Stern AM, Markel H. The history of vaccines and immunization: familiar patterns, new challenges. Health Aff. 2005;24:611-621.